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Background: Licensed for use in males in 2009, Human Papillomavirus (HPV) vaccination rates in adolescent males
are extremely low. Literature on HPV vaccination focuses on females, adult males, or parents of adolescent males,
without including adolescent males or the dynamics of the parent-son interaction that may influence vaccine
decision-making. The purpose of this paper is to examine the decision-making process of parent-son dyads when
deciding whether or not to get vaccinated against HPV.
Methods: Twenty-one adolescent males (ages 13–17), with no previous HPV vaccination, and their parents/
guardians were recruited from adolescent primary care clinics serving low to middle income families in a large
Midwestern city. Dyad members participated in separate semi-structured interviews assessing the relative role of the
parent and son in the decision regarding HPV vaccination. Interviews were recorded, transcribed, and coded using
inductive content analysis.
Results: Parents and sons focused on protection as a reason for vaccination; parents felt a need to protect their
child, while sons wanted to protect their own health. Parents and sons commonly misinterpreted the information
about the vaccine. Sons were concerned about an injection in the penis, while some parents and sons thought the
vaccine would protect them against other sexually transmitted infections including Herpes, Gonorrhea, and HIV.
Parents and sons recalled that the vaccine prevented genital warts rather than cancer. The vaccine decision-making
process was rapid and dynamic, including an initial reaction to the recommendation for HPV vaccine, discussion
between parent and son, and the final vaccine decision. Provider input was weighed in instances of initial
disagreement. Many boys felt that this was the first health care decision that they had been involved in. Dyads
which reported shared decision-making were more likely to openly communicate about sexual issues than those
that agreed the son made the decision.
Conclusion: Parents and sons play an active role in the decision-making process, with an individual’s role being
influenced by many factors. The results of this study may be used to guide the messages presented by clinicians
when recommending the HPV vaccine, and future vaccine uptake interventions.
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Human papillomavirus (HPV) is the most common
sexually transmitted infection (STI) in both men and
women [1]. In 2006 the HPV vaccine was licensed in
females ages 9-26 [2], and given a routine recommenda-
tion by the U.S. Advisory Committee on Immunization
Practices (ACIP) [3]. This vaccine was actively promoted
by pharmaceutical companies and quickly became a part
of the health care agenda, resulting in moderate levels of
vaccination. In 2009, the quadrivalent HPV vaccine was
licensed in the U.S. for males ages 9–26 [4] as well, but
with a permissive, rather than routine, recommendation
by the ACIP [5], which left the decision to vaccinate to
the discretion of the health care provider and/or parents.
Additionally, this licensure and recommendation was
not followed by a strong advertising campaign, or given
a great deal of attention by the health care system. In
2010, 1.4% of males ages 13–17 received at least one
dose of the HPV vaccine [6]. In October, 2011 the ACIP
revised their recommendation for the HPV vaccine in
males from permissive to routine [7]; however, it is still
too early to determine the effect this new recommenda-
tion has had on vaccine uptake in the adolescent male
population. Internationally, male HPV vaccination has
also lagged, but Australia intends to begin routine
school-based vaccination for males in late 2012 [8]. In
order to understand more about HPV vaccination in
males and to inform vaccine uptake interventions, the
purpose of this study was to utilize qualitative methods
to examine the decision-making process of parent-son
dyads when deciding whether or not to get vaccinated
against HPV.
Current literature on HPV vaccination in males predom-
inantly focuses on the adult male population and has indi-
cated high levels of acceptability of the quadrivalent HPV
vaccine [9-13], but low awareness that the vaccine is
currently available to males [11,14]. The few studies that
have looked at the parents of adolescent males have found
moderate [14] to high levels of vaccine acceptability with
lower levels of intent to vaccinate their own sons [15]. Add-
itionally, there were low levels of HPV knowledge [14] and
limited awareness that the vaccine was available in males
[14,16]. Furthermore, a survey of a national sample of
parents of adolescent males found that only 2% of the sons
had been vaccinated with 50% of these primarily due to
doctor recommendation. At the same time, only 3% of the
unvaccinated sons in this sample received a recommenda-
tion from their doctor [16]. Other research on providers’
attitudes towards male HPV vaccination have found that
only 12% of pediatric and family medicine providers offered
vaccination [17]. A recent study of older adolescents in
England suggested that 16–18 year old males found the
vaccine acceptable, although there has been no recommen-
dation to vaccinate males in that country [18]. A moredetailed recent review of male HPV vaccine literature can
be found elsewhere [19].
While there has been more research on HPV vaccine in
females, the subset of that literature that is most relevant
to the current study is that of parent-daughter decision-
making. This body of literature has shown that decision-
making between parents and daughters is dynamic and
involves a transactional process between dyad members
[20,21]. Factors that influence a dyad’s decision to receive
the HPV vaccine include physician recommendation
[22-24], endorsement by significant others, such as par-
ents, partners, and friends [21,25-27], and concern over
the short length of time the vaccine had been licensed
[28]. While we can utilize this information to inform the
current study, current literature lacks information on how
parents and sons make the decision to get vaccinated
against HPV.
Due to the relatively recent licensure of the HPV
vaccine in males in conjunction with the lack of know-
ledge about HPV vaccine decision-making in this popula-
tion, we conducted a qualitative study of parent-son dyads
immediately after they have been offered and made the
decision to receive/refuse the HPV vaccine. Qualitative
methods are ideal when little is known about a topic, such
as point of care and joint decision-making. The objective
of this study was to learn more about the structure and
process of decision-making used by parents and sons
when deciding to receive/refuse the HPV vaccine by
examining, first, the initial reaction of each dyad member
to the physician recommendation of the HPV vaccine, and
then, the dyadic decision-making process.
Methods
Sample
Adolescent males, 13–17 years of age, and their parents
or guardians (referred to as parents) were recruited from
adolescent primary care clinics serving primarily lower
income families in Indianapolis, Indiana, U.S. This age
range was chosen because parental consent in Indiana is
required for all vaccines for individuals under 18 years
of age. Participants could not have received any HPV
vaccine prior to the current health care visit and had to
be accompanied by a parent or guardian. Otherwise
eligible participants were excluded if a sibling already
participated in the study. Both male and female parents
were eligible to participate. A total of 23 parent-son
dyads were approached for participation in the study.
Two dyads refused participation, both due to time con-
straints. Therefore, a total of 21 dyads (42 interviews)
participated in this study. This study was approved by
the Indiana University Institutional Review Board.
All providers in these clinics routinely recommended
the HPV vaccine to their eligible male patients, even prior
to the revised ACIP recommendation. Lack of provider
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therefore, this design allows us to control for provider
recommendation, and focus, instead, on the parent-son
decision-making process.
Procedures
During the clinic visit, prospective participants were seen
by their provider and offered any ACIP-indicated vaccines
as part of routine clinical care, including HPV vaccine. All
study interviews occurred after the provider had finished
and the parent-son dyad had either agreed or refused
HPV vaccination. The research team approached the dyad
immediately after the clinic visit, explained the study, and
obtained parental consent and adolescent assent to
participation. The parent-son dyad was then separated for
simultaneous 30–60 minute interviews conducted in
separate rooms with separate interviewers.
Data collection
Once in the interview room, each participant was admi-
nistered a demographic questionnaire by the interviewer
to gather information such as age, marital status, educa-
tion level, siblings/other children, and home compo-
sition. Subsequently, parents and sons completed a
semi-structured interview aimed at eliciting the details
of the decision-making process related to HPV vac-
cination. Interviewees were asked to reflect on the HPV
vaccination decision just made. A total of 11 primary
questions were asked of both parents and adolescents.
Topics covered included HPV vaccine knowledge, infor-
mation provided by the doctor, and the decision-making
process. Each primary question was followed by probe
questions. Interviewers listened for completeness and
consistency in responses, asking participants to clarify
and/or further explain their answers. An example of a
primary question of parents with probes is illustrated by
the following:
Primary Question: “How did you decide to get the
vaccine?”
Probe 1: “What was said between you and your son
when deciding to get the vaccine?”
Probe 2: “What factors played a major role in your
decision?”
Probe 3: “What factors do you feel played a major role
in your son’s decision?”
Each interview was audio recorded and transcribed.
After each interview, the interviewer wrote up detailed
field notes intended to document information not cap-
tured on the audio recording including an assessment of
interview flow, pertinent background information on the
participant, the setting and tone of the interview, as wellas a detailed summary of the interview highlighting key
points around decision-making.
Analysis
Data were analyzed according to the method of induct-
ive content analysis [29]. This method of content
analysis is utilized when little is known about a topic or
the knowledge is fragmented. This process of analysis
includes open coding, creating categories, and abstrac-
tion, and tends to move from very specific to more
general in order to create a picture of the larger whole.
This method of analysis was chosen to facilitate the
identification of dyad types, how they interact as a
whole, and how they differ individually.
Two researchers read and openly coded 12 randomly
chosen interviews identifying emerging issues, concepts,
and themes surrounding the decision-making process
used by male adolescents and their parent(s). The
researchers then came together and discussed their indi-
vidual codes and created a list of preliminary codes.
Example codes include previous vaccine awareness, pain,
protection, genital warts, and health. These codes were
entered into NVIVO 9 (QSR International, 2011).The
researchers then read through and coded the parent and
son interviews, separately, in order to understand how the
individual decision was made. Next, the researchers read
through and coded the interviews in dyads in order to
understand how the decision was made together and how
each dyad member influenced the other. Once all inter-
views were read through both separately and together, a
preliminary model was created. The model was expanded
and adjusted throughout the process of coding, recoding,
and sub-coding. The research team met numerous times
until no new themes or changes to the model were





The majority of adolescents in this study were Black
(n = 14), followed by Hispanic (n = 5), and White (n = 2).
Adolescent age ranged from 13–17 with the majority being
14 years old (n = 6) followed by 15 and 16 (n = 5 each). All
but two of the adolescents had siblings.
Parents
The majority of parents were female (n = 17). Parents
ranged in age from 31–53 (M = 38.9, SD = 5.99). The
majority of parents were single (n = 12), followed by
married (n = 6). Half of the parents had at least a high
school education (n = 11). The number of children of
each parent ranged from 1–11 (M = 3.71, SD = 2.51).
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The conversation regarding vaccines was initiated at the
end of the clinic visit by the physician for all but one
dyad. In this dyad, the primary reason for the physician
visit was vaccination for school, and thus, the topic was
brought up by the parent. Unless the adolescent was up
to date on all of their other vaccinations, the HPV vac-
cine was discussed along with the other routine vaccines
given during adolescence. Most dyads could not recall
exactly which vaccines were offered or received, for
some this included HPV vaccine.
While the information presented to the dyads varied
by physician (as recalled by each dyad member), each
dyad felt the physician spent more time explaining the
HPV vaccine than they did other vaccines offered that
day. The reported physician message components
included: (1) prevention against genital warts, (2) pre-
vention against cancer, (3) recent approval in males, and
(4) vaccine safety. While at least some dyads recalled the
mention of cancer, the types of cancers varied. Most
dyads recalled the discussion of anal and penile cancer.
The dyads of one physician in particular tended to stress
the rarity of these cancers. Additionally, a subset of
physicians also reportedly mentioned protection against
cervical cancer in girls. Although dyads could recall that
most physicians mentioned that the vaccine was safe,
most could not recall if the physician spoke specifically
of the side effects of the vaccine, and most dyads did not
ask about them. While providing information about the
vaccine to the dyads, the physicians reportedly tended to
look at both the parent and the adolescent throughout
the conversation. This approach was not the case, how-
ever, for those adolescents with non-English speaking
parents. In these instances, the dyads reported the phys-
ician looking at and discussing the vaccine directly with
the adolescent.
After the vaccine was presented to each dyad by the
physician, some asked the physician questions about the
vaccine, including questions about vaccine safety, effi-
cacy, and reasons for recent availability for males.
After questions about the vaccine were answered or
the physician completed the discussion of the HPV
vaccine (in instances where no questions were asked),
the dyads were often asked if they wanted the HPV
vaccine independent of their decision about the other
vaccines offered that day. For the most part, the answer
was given to the physician by the parent. However, in all
but a few instances the adolescent also gave verbal or
non-verbal cues of acceptance, which were often elicited
by either the parent or the physician. When elicited by
the physician, the adolescent was explicitly asked if they
wanted the vaccine after the parent had given their
response. Elicitation by parent occurred via a wide range
of actions. Some parents explicitly asked the adolescentif they wanted the vaccination, similar to the physician.
Other parents simply looked at their child, which then
resulted in a verbal, “Okay,” or a nod, smile, or other
method of non-verbal communication. While the phys-
ician elicitation occurred after the parental response, the
parental elicitation took place either before or after the
parental response was given. When adolescent opinion
was not elicited by either parent or physician, it was due
to the adolescent’s lack of engagement in the conversa-
tion or the parent’s strong opinion about the vaccine.
All but two of the dyads received HPV vaccine and most
dyads were concordant in this decision. However, both the
recall of the conversation with the physician and the
reasons for vaccination often differed between parent and
son (Table 1). For the two cases of vaccine refusal, one
involved a father who did not want to make a decision
without consulting his wife and the other one involved an
adolescent son who was very scared of needles.
HPV vaccine decision-making among parents
Parents recalled a wide variety of information from the
conversation with providers. The most common piece of
information recalled was that the vaccine protected
against genital warts, followed by cancer, and an STI.
Other pieces of information commonly recalled by par-
ents included the recent vaccine availability for males,
that the vaccine was optional, and that the vaccine
should, ideally, be given before the adolescent becomes
sexually active. Most did not mention that HPV vaccin-
ation involves three doses.
The most commonly stated reason for getting sons
vaccinated was parental interest in protecting their
children from harm. Parents felt it was their job to
protect their sons, and as long as the vaccine was safe,
they felt that their sons should get it. Some parents
specifically mentioned prevention of genital warts and/
or cancer, but the large majority discussed protection
and safety in more general terms. One parent felt the
vaccine’s ability to prevent her son from spreading the
infection was a benefit. Many parents were concerned
that adolescents in general are having sex at younger
ages, and that there are more STIs present than when
they were growing up. For example, one parent said,
“Cause. . .kids now a days are just too active. I mean,
there’s just too much out there. It ain’t like it was when
we was coming up (Female, 34 years old).” An added
worry was parental concern about limited ability to
monitor their sons’ activities (see Table 1, Q1.6 for
example quote). Even for parents who were confident
that their sons were not having sex, an important reason
for vaccination was the realization that their sons may
soon become sexually active.
With respect to safety, the large majority of parents
felt there were no significant risks associated with HPV
Table 1 Factors in individual HPV vaccination decision
Factors of Individual Decision Son Parent
Details from doctor Protection Genital warts
Genital warts Cancer
Sexually Transmitted Infection Sexually Transmitted Infection
Cancer Male availability
Gonorrhea Optional
Male availability Before sexual initiation
Three shots
Example Quote Q1.1 “She was just saying it was for, you get it to
prevent. . .you from catching genital warts and uh, she
said it used to be for girls but uh, they just passed a law
that it’s for boys and girls now (15 years old).”
Q1.5 “She just mentioned the [vaccine], and I told her I
didn’t realize it was for males also [be]cause my daughter
just finished her series of it. And then she explained to me
how it can help with things like genital warts and penile
cancer, and just that there are things that can be
prevented in boys the same as girls. (Female, 40).”
Reasons for vaccination Protection General protection of son
Safety Vaccine is safe
Stay healthy Sexual initiation soon
Anticipated regret
Example Quote Q1.2 “So I can stay healthy. I don’t want to mess with
them [viruses]. I don’t want to die, or I don't want to be
sitting in a hospital. If there’s anything to keep myself
away from it I’ma do it (15 years old).”
Q1.6 “I try very hard to protect him as much as I can
because I’m not there 24 hours a day. So, I can’t walk
around with, I can’t put him in a condom and hold him
in there (Female, 33 years old).”
Risks Pain Side effects
Shot in penis Questions about sex from son
Example Quote Q1.3”It hurts. I believe that that painful needle will
protect me, so I’m gonna get it (13 years old).”
Q1.7 “We heard when she got hers, that some kid died
because they got vaccinated, that in some places they
have some negative reactions, but it’s a risk. Everything
has a risk (Female, 38 years old).”
Benefits Protection Genital warts
Safety Cancer
Stay healthy Sexually Transmitted Infection
Example Quote Q1.4”Like this keeps you safe so you won’t be like hurt
or anything like that. I guess just keep you healthy, make
sure you like don’t spread it or anything like that
(15 years old).”
Q1.8 “Well, the good thing is that if he decides to get
sexually active that he’s protected on that [HPV]. Along
with all the other protections that are out there (Female,
34 years old).”
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ician discussing potential minor side effects associated
with the vaccine (e.g., pain at injection site) and they did
not view these side-effects as reason to not vaccinate.
Two parents felt that there were potential risks asso-
ciated with the vaccine (e.g., worries that the adolescent
will incorrectly assume that the parent endorses initi-
ation of sexual activity). Nonetheless, in both of these
cases the sons received HPV vaccine.
HPV vaccine decision-making among sons
The majority of adolescents recalled the physician
mentioning that the vaccine was preventive and they most
frequently mentioned protection against genital warts,
followed by protection against an STI and cancer. How-
ever, a number of adolescents could not recall anything
the physician said about the HPV vaccine, and a smallnumber thought the vaccine protected against gonorrhea.
Reasons for choosing to get vaccinated included protec-
tion against disease, to stay healthy, and feeling it would
be their fault if they did not get the shot and ended up
catching the disease (i.e., anticipated regret).
Examination of individual decision-making processes
showed that the sons actively weighed their perceived
risks and benefits of HPV vaccination. Most of the
adolescents who said that they wanted the vaccine talked
about the benefits, but reported few perceived risks.
When perceived risks were present, pain related to the
injection was the most common concern. However, in
these cases, the adolescents stated that the pain was not
enough of a reason to refuse vaccination (see Table 1,
Q1.3 for example quote). Some of the adolescents who
initially were reluctant to get vaccinated were concerned
that they were going to get the shot in their penis. After
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went ahead and got vaccinated.
Dynamics of parent-son decision-making process
Although many dyads were in agreement in their initial
views toward vaccination, there was some disagreement.
For the most part, the disagreement was due to the
parent endorsing vaccination, and the son expressing re-
luctance. The most common reasons given for the son
initially not wanting the vaccine were dislike of needles,
being abstinent, and not understanding why the vaccine
was needed. When one member of the dyad was un-
decided and the other member held a decisive opinion,
the final decision coincided with the wishes of the latter.
Disagreement was resolved via a conversation between
parent and son, with some dyads bringing the physician
into the conversation. For example, in one dyad it was
determined that the reason the son did not want to get
vaccinated was because he did not understand why he
needed the vaccine as he was not sexually active, and
did not plan on becoming active in the near future. In
this case, physician input was elicited by the parent to
explain why the vaccination was needed now. Ultimately,
there was agreement across all dyads regarding the final
vaccination decision, with the majority of dyads accept-
ing vaccination (Figure 1).
Analysis of parent-son dyads showed that each member
of the dyad had one of three possible views regarding the
balance of decision-making. These included the percep-
tion of the parent as the decision-maker, the son as the de-
cision-maker, or the parent and son both participating in
the decision. Example quotes from dyads in each category
are presented in Table 2. In about half of the dyads, there
was concordance regarding decision-making, with most of
these dyads perceiving the decision as either shared orInitial Individual 










Figure 1 HPV vaccine decision-making process as reported in the intemade by the son. Even when there was discordance, in
most cases, parents and sons ultimately agreed on the
final vaccination decision.
The majority of sons felt that they had a role in the
vaccination decision, and most of their parents agreed.
Most adolescents expressed positive feelings about being
included in this decision and many said that this was the
first time they had experienced any level of autonomy
when it came to decisions about their health. For example,
when asked how being included in this decision made him
feel, one participant responded: “This was like one of the
first things that I really got the decision on. And I kinda
made the decision wisely because anything to make me
stay healthy I’d rather do that (Son, 13 years old).” Many
parents also felt this was the first time their son was
included in a medical decision and viewed the issue as a
matter of personal choice. For example, when asked if
adolescents should be forced to get this vaccine, one par-
ent responded, “I mean because, it’s like sex is their own,
that’s up to them to make that decision. It’s their sexual
decision, so as far as forcing them, it’s like forcing them to
carry a condom in their pocket (Male, 31 years old).”
When both dyad members endorsed shared decision-
making (n = 5) parents also reported open communica-
tion about sex or awareness that their sons were sexually
active. When both dyad members agreed that the son
made the decision, parents typically indicated that they
did not openly communicate about sex and were unsure
of their child’s sexual activity or confident that their
child was not having sex.
Discussion
The findings from this study suggest, in many cases,
HPV vaccine decision-making for adolescent males














Table 2 Criteria for role assignment in dyadic decision to get vaccinated
Parent Both Son
Criteria •Parent and/or son explicitly stated parent
made decision on own.
•Son asked questions and/or was
engaged in the conversation, and the
parent stated their opinion or gave an
answer to the doctor.
•Parent explicitly stated that they let
their son make the decision.
•Parent gave the answer to the physician
without any attempt to include their son in
the decision.
•Parent explicitly asked for son’s opinion •Son explicitly stated that he made
the decision alone.
Example Quote Q2.1 I looked at him and he looked at me
and I said, “You’re gonna get that.” I mean, it
wasn’t even a question. He’s 15 years old
(Female, 35 years old).
Q2.2 My mom looked at me and asked
me if I wanted it and I said yea. Then my
mom said yea (Son, 15 years old).
Q2.3 Interviewer: Who do you think
made the decision?
Son: Me.
Interviewer: So, what kinds of things
were going through your head when
you decided that?
Son: I don’t want to get no shot right
now (Son, 16 years old).
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provider. We found that protection against genital warts
was perceived as a major benefit of vaccination, followed
by cancer prevention. Although each of the providers
reportedly discussed the HPV vaccine protecting against
both genital warts and cancer, both parents and sons
emphasized protection against genital warts as a main
reason for vaccination. This is different from what has
been found in the female population [30], but consistent
with past research from mothers of sons [16,31], and
should be considered by clinicians when recommending
the vaccine to adolescent males and their parents.
When elaborating on protection, parents tended to
focus on the need to protect their child from harm
anyway they could. Complementary to this, sons focused
on the need to maintain their health. This finding is
consistent with other research on vaccine acceptability
[32] and suggests that the way clinicians present the
vaccine may need to address vaccination as a health
maintenance as well as a disease prevention measure.
Although this study took place in adolescent-focused
clinics with experienced adolescent health care pro-
viders, parents and sons still came away with some
notable misinterpretations about both the benefits and
risks of vaccination. Quite a few sons were concerned
about getting an injection in their penis. Additionally,
some parents and sons thought the HPV vaccine would
protect them against other STIs including herpes, gonor-
rhea, and HIV. These misinterpretations emphasize the
importance of clinicians providing clear and repeated
information when presenting the HPV vaccine to adoles-
cent males and their parents.
While the details of the conversation with the doctor
differed between dyad members, the general components
of the message were similar. However, there were still quite
a few dyads that were in disagreement regarding their ini-
tial reaction to the vaccine. Through verbal and non-verbalcommunication, as well as periodic information provision
by the clinician, disagreements were resolved and dyads
came to final vaccination decisions together. The involve-
ment of sons in the decision-making process was perceived
to be a unique and positive experience by both parents and
sons, which is consistent with other research on HPV
vaccination [14,15], though past research on hypothetical
STI and HPV vaccines found mixed results on autonomy
and locus of decision-making [28,33-35]. Nonetheless, the
increased participation in vaccination decision-making that
we identified should be considered by clinicians as their
patients progress into adolescence.
Limitations
While the qualitative design of this study allowed us to
examine in-depth information about parent-son deci-
sion-making around the HPV vaccine, there are a num-
ber of limitations. Although a sample size of 21 pairs of
interviews is adequate for qualitative research, it limits
the generalizability of these findings. Thus, care should
be taken when applying the findings of this study to a
larger population. Additionally, while this study provides
a good starting point to understanding the process of
vaccine decision-making among parents and sons, the
data collection sites were clinics with particularly high
adolescent vaccination rates. Research should be con-
ducted in clinics with low vaccination rates as well as
with non-clinical samples in order to better understand
the range of issues surrounding HPV vaccination in males.
Furthermore, although the study population included
males ages 13–17, the vaccine is licensed to males ages
9–26. Therefore, care should be taken when applying
these results to the entire range of eligible males. Finally,
it is important to acknowledge the inherent power differ-
ential between parents and their sons, particularly in the
context of a health care visit. It is possible that this power
differential may have influenced, to some degree, the way
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made efforts to minimize this issue by interviewing
parents and sons separately. Future studies will want to
explore, as well, the ways in which vaccination status of
sisters may influence parent-son decision-making about
HPV vaccination.
Conclusions
There were many perceived benefits and few perceived
risks associated with HPV vaccination of males. Decision-
making about vaccination was an activeprocess involving
both parents and sons. The health care provider was seen
as playing an essential role in providing information and
correcting misperceptions about HPV vaccination. Fur-
thermore, this particular decision may provide an oppor-
tunity for the adolescents to become involved with
decisions about their health care. Clinicians may use the
results of this study to inform the way they present
information on HPV vaccine to adolescent male patients
and their parents.
Abbreviations
ACIP: Advisory committee on immunization practices; HIV: Human
immunodeficiency virus; HPV: Human papillomavirus; STI: Sexually
transmitted infection.
Competing interests
GDZ has served as a paid research consultant to Sanofi Pasteur. ABA, NWS,
and GDZ are investigators on investigator-initiated research studies funded
by Merck & Co., Inc. including the grant that funded the research reported in
this manuscript (MISP #38094). The funder did not have a role in the study
design, in the collection, analysis, and interpretation of data, in the writing of
the report, nor in the decision to submit the article for publication. All other
authors declare that they have no competing interests.
Authors’ contributions
ABA contributed to the conception and design of the study, participated in
acquisition of the data, analysis, and interpretation of the data, and drafted
the manuscript. NWS contributed to the conception and design of the study,
participated in acquisition of the data, analysis, and interpretation of the
data, and critically revised the manuscript for important intellectual content.
MAO, DH, and MR contributed to the design of the study, and critically
revised the manuscript for important intellectual content. GDZ contributed
to the conception and design of the study, interpretation of the data, and
critically revised the manuscript for important intellectual content. All authors
read and approved the final manuscript.
Acknowledgements
This study was funded by an investigator-initiated grant from Merck and Co.,
Inc. (MISP #38094). The funder did not have a role in the study design, in the
collection, analysis, and interpretation of data, in the writing of the report, or
in the decision to submit the article for publication.
Author details
1Center for Sexual Health Promotion, Indiana University, Bloomington, IN,
USA. 2Section of Adolescent Medicine, Indiana University, Indianapolis, IN,
USA. 3Indiana University School of Medicine, 410 West Tenth Street, HS 1001,
Indianapolis, IN 46202, USA.
Received: 16 April 2012 Accepted: 11 December 2012
Published: 14 December 2012
References
1. Centers for Disease Control and Prevention: Genital HPV Infection – Fact Sheet.
http://www.cdc.gov/std/HPV/STDFact-HPV.htm (accessed 12/13/2012).2. U S Food and Drug Administration: Product approval – Licensing action:
Gardasil(R); 2006. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/
QuestionsaboutVaccines/ucm096052.htm (accessed 12/13/2012).
3. Markowitz LE, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E:
Quadrivalent human papillomavirus vaccine. Morb Mortal Wkly Rep 2007,
56(RR02):1–24.
4. US Food and Drug Administration: Gardasil Approval Letter; 2009. http://
www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/
ucm186991.htm (accessed 12/13/2012).
5. Centers for Disease Control and Prevention: FDA licensure of quadrivalent
human papillomavirus vaccine (HPV4, Gardasil) for use in males and
guidance from the Advisory Committee on Immunization Practices
(ACIP). MMWR Morb Mortal Wkly Rep 2010, 59:630–632.
6. Centers for Disease Control and Prevention: National and state vaccination
coverage among adolescents aged 13 through 17 years-United States
2010. MMWR 2011, 60:1117–1123.
7. Center for Disease Control and Prevention: Recommendations on the use
of quadrivalent human papillomavirus vaccine in males--Advisory
Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal
Wkly Rep 2011, 60(50):1705–1708.
8. Australian Government Department of Health and Ageing: HPV vaccine
extended to boys. http://www.health.gov.au/internet/ministers/publishing.
nsf/Content/59C397F61CACF02FCA257A390000C65A/$File/TP059.pdf.
(accessed 12/13/2012).
9. Jones M, Cook R: Intent to receive an HPV vaccine among university men
and women and implications for vaccine administration. J Am Coll Health
2008, 57(1):23–32.
10. Reiter PL, Brewer NT, Smith JS: Human papillomavirus knowledge and
vaccine acceptability among a national sample of heterosexual men.
Sex Transm Infect 2010, 86(3):241–246.
11. Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS: Acceptability of HPV
vaccine among a national sample of gay and bisexual men. Sex Transm
Dis 2010, 37(3):197.
12. Gilbert P, Brewer NT, Reiter PL, Ng TW, Smith JS: HPV vaccine acceptability
in heterosexual, gay, and bisexual men. Am J Mens Health 2011, 5(4):297.
13. Gilbert PA, Brewer NT, Reiter PL: Association of human papillomavirus-
related knowledge, attitudes, and beliefs with HIV status: a national
study of gay men. J Low Genit Tract Dis 2011, 15(2):83.
14. Reiter PL, McRee A-L, Gottlieb SL, Brewer NT: HPV vaccine for adolescent
males: acceptability to parents post-vaccine licensure. Vaccine 2010,
28:6292–6297.
15. Dempsey AF, Butchart A, Singer D, Clark S, Davis M: Factors associated
with parental intentions for male human papillomavirus vaccination:
results of a national survey. Sex Transm Dis 2011, 38(8):769–776.
16. Reiter PL, McRee A-L, Kadis JA, Brewer NT: HPV vaccine and adolescent
males. Vaccine 2011, 29(34):5595–5602.
17. Perkins RB, Clark JA: Providers’ attitudes toward human papillomavirus
vaccination in young men: challenges for implementation of 2011
recommendations. Am J Mens Health 2012, 6(4):320–323.
18. Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J: Interest in having
HPV vaccination among adolescent boys in England. Vaccine 2012,
30(30):4505–4510.
19. Stupiansky NW, Alexander AB, Zimet GD: Human papillomavirus vaccine
and men: what are the obstacles and challenges? Curr Opin Infect Dis
2012, 25(1):86.
20. Cox DS, Cox AD, Sturm L, Zimet G: Behavioral interventions to increase
HPV vaccination acceptability among mothers of young girls.
Health Psychol 2010, 29(1):29.
21. Roberts ME, Gerrard M, Reimer R, Gibbons FX: Mother-daughter
communication and human papillomavirus vaccine uptake by college
students. Pediatrics 2010, 125(5):982.
22. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD:
Predictors of HPV vaccine uptake among women aged 19-26:
Importance of a physician's recommendation. Vaccine 2011,
29(5):890–895.
23. Gerend MA, Weibley E, Bland H: Parental response to human
papillomavirus vaccine availability: uptake and intentions. J Adolesc
Health 2009, 45(5):528–531.
24. Dempsey AF, Abraham LM, Dalton V, Ruffin M: Understanding the reasons
why mothers do or do not have their adolescent daughters vaccinated
against human papillomavirus. Ann Epidemiol 2009, 19(8):531–538.
Alexander et al. BMC Pediatrics 2012, 12:192 Page 9 of 9
http://www.biomedcentral.com/1471-2431/12/19225. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA:
Human papillomavirus vaccine uptake, predictors of vaccination, and
self-reported barriers to vaccination. J Womens Health 2009,
18(10):1679–1686.
26. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD: Rates of
human papillomavirus vaccination, attitudes about vaccination, and
human papillomavirus prevalence in young women. Obstet Gynecol 2008,
111(5):1103–1110. doi:1110.1097/AOG.1100b1013e31817051fa.
27. Zimet GD, Perkins SM, Sturm LA, Bair RM, Juliar BE, Mays RM: Predictors of
STI vaccine acceptability among parents and their adolescent children.
J Adolesc Health 2005, 37(3):179–186.
28. Hughes C, Jones A, Feemster K, Fiks A: HPV vaccine decision making in
pediatric primary care: a semi-structured interview study. BMC Pediatr
2011, 11(1):74.
29. Elo S, Kyngäs H: The qualitative content analysis process. J Adv Nurs 2008,
62(1):107–115.
30. Leader AE, Weiner JL, Kelly BJ, Hornik RC, Cappella JN: Effects of
information framing on human papillomavirus vaccination. J Womens
Health 2009, 18(2):225–233.
31. Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB,
del Carmen MG: HPV vaccine: a comparison of attitudes and behavioral
perspectives between latino and non-latino women. Gynecol Oncol 2009,
112(3):577–582.
32. Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, Wilson C:
Men’s Attitudes toward receiving the human papillomavirus vaccine.
J Low Genit Tract Dis 2008, 12(4):276–281. doi:210.1097/
LGT.1090b1013e318167913e.
33. Benin AL, Wu AC, Holmboe ES, Shapiro ED, Anyan W: How can we
communicate about vaccines with adolescents and their parents?
Clin Pediatr 2010, 49(4):373–380.
34. Brabin L, Roberts SA, Farzaneh F, Kitchener HC: Future acceptance of
adolescent human papillomavirus vaccination: a survey of parental
attitudes. Vaccine 2006, 24(16):3087–3094.
35. Juliar BE, Bair RM, Zimet GD, Sturm LA, Mays RM, Perkins SM: Concordance in
decision making for STD vaccination between parents and adolescents.
Jacksonville, FL: National STD Prevention Conference; 2006.
doi:10.1186/1471-2431-12-192
Cite this article as: Alexander et al.: Parent-son decision-making about
human papillomavirus vaccination: a qualitative analysis. BMC Pediatrics
2012 12:192.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
